Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals

References

• Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–511. doi:10.1161/CIRCULATIONAHA.107.706127
   PubMed Web of Science ®Google Scholar
• Resnick LM, MÜLler FB, Laragh JH. Calcium-regulating hormones in essential hypertension: relation to plasma renin activity and sodium metabolism. Ann Intern Med. 1986;105(5):649–654. doi:10.7326/0003-4819-105-5-649
   PubMedGoogle Scholar
• Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003;41(1):105–112. doi:10.1016/S0735-1097(02)02624-4
   PubMedGoogle Scholar
• Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997;96(6):1755–1760. doi:10.1161/01.CIR.96.6.1755
   PubMed Web of Science ®Google Scholar
• Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol. 1990;19(3):559–563. doi:10.1093/ije/19.3.559
   PubMedGoogle Scholar
• Poole KES, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke. 2006;37(1):243–245. doi:10.1161/01.STR.0000195184.24297.c1
   PubMed Web of Science ®Google Scholar
• Pilz S, März W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93(10):3927–3935. doi:10.1210/jc.2008-0784
   PubMed Web of Science ®Google Scholar
• Lind L, Hänni A, Lithell H, Hvarfner A, Sörensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995;8(9):894–901. doi:10.1016/0895-7061(95)00154-H
   PubMed Web of Science ®Google Scholar
• Imga NN, Karci AC, Oztas D, Berker D, Guler S. Effects of vitamin D supplementation on insulin resistance and dyslipidemia in overweight and obese premenopausal women. Arch Med Sci. 2019;15(3):598. doi:10.5114/aoms.2018.75864
   PubMedGoogle Scholar
• Faridi KF, Zhao D, Martin SS, et al. Serum vitamin D and change in lipid levels over 5 y: the atherosclerosis risk in communities study. Nutrition. 2017;38:85–93. doi:10.1016/j.nut.2017.01.008
   PubMedGoogle Scholar
• Lupton JR, Faridi KF, Martin SS, et al. Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: the Very Large Database of Lipids (VLDL-3) study. J Clin Lipidol. 2016;10(1):72–81. doi:10.1016/j.jacl.2015.09.006
   PubMed Web of Science ®Google Scholar
• Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr. 2010;64(12):1457. doi:10.1038/ejcn.2010.176
   PubMedGoogle Scholar
• Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW. Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation. 2012;126(3):270–277. doi:10.1161/CIRCULATIONAHA.111.077875
   PubMed Web of Science ®Google Scholar
• Wang H, Xia N, Yang Y, Peng D-Q. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis. 2012;11(1):42. doi:10.1186/1476-511X-11-42
   PubMedGoogle Scholar
• Jorde R, Grimnes G. Vitamin D and Lipids: Do We Really Need More Studies? Am Heart Assoc; 2012.
   Google Scholar
• Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14(3–4):222–231. doi:10.2119/2007-00119.Tilg
   PubMed Web of Science ®Google Scholar
• Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem. 2003;278(46):45777–45784. doi:10.1074/jbc.M301977200
   PubMed Web of Science ®Google Scholar
• Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J. Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol. 2011;27(2):174–182. doi:10.1016/j.cjca.2010.12.040
   PubMed Web of Science ®Google Scholar
• Aso Y, Fujiwara Y, Tayama K, Takanashi K, Inukai T, Takemura Y. Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor. Exp Clin Endocrinol Diabetes. 2001;109(04):210–216. doi:10.1055/s-2001-15108
   PubMedGoogle Scholar
• Després J-P, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334(15):952–958. doi:10.1056/NEJM199604113341504
   PubMed Web of Science ®Google Scholar
• Sulaiman N, Albadawi S, Abusnana S, et al. High prevalence of diabetes among migrants in the United Arab Emirates using a cross-sectional survey. Sci Rep. 2018;8(1):1–8. doi:10.1038/s41598-018-24312-3
   PubMedGoogle Scholar
• Hamoudi R, Sharif-Askari NS, Sharif-Askari FS, et al. Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates. Sci Rep. 2019;9(1):1–7. doi:10.1038/s41598-019-53505-7
   PubMedGoogle Scholar
• Ersfeld DL, Rao DS, Body -J-J, et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON® automated analyzer. Clin Biochem. 2004;37(10):867–874. doi:10.1016/j.clinbiochem.2004.06.006
   PubMed Web of Science ®Google Scholar
• Rusińska A, Płudowski P, Walczak M, et al. Vitamin D supplementation guidelines for general population and groups at risk of vitamin D deficiency in Poland—recommendations of the polish society of pediatric endocrinology and diabetes and the expert panel with participation of national specialist consultants and representatives of scientific societies—2018 update. Front Endocrinol (Lausanne). 2018;9:246. doi:10.3389/fendo.2018.00420
   PubMed Web of Science ®Google Scholar
• Al Sayed N, Al Waili K, Alawadi F, et al. Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East. Int J Cardiol. 2016;225:268–283. doi:10.1016/j.ijcard.2016.09.081
   PubMed Web of Science ®Google Scholar
• Reiner Ž, Catapano AL, De Backer G, et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32(14):1769–1818. doi:10.1093/eurheartj/ehr158
   PubMed Web of Science ®Google Scholar
• Hamer M, O’Donovan G, Stamatakis E. High-density lipoprotein cholesterol and mortality: too much of a good thing? Arterioscler Thromb Vasc Biol. 2018;38(3):669–672. doi:10.1161/ATVBAHA.117.310587
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Ashraf H, Khalilzadeh O, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab. 2010;7(1):26. doi:10.1186/1743-7075-7-26
   Google Scholar
• Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;13(1):47. doi:10.1186/1472-6823-13-47
   PubMedGoogle Scholar
• Kabadi SM, Lee BK, Liu L. Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001–2006. Diabetes Care. 2012;35(10):2048–2054. doi:10.2337/dc12-0235
   PubMedGoogle Scholar
• Steyerberg EW, Eijkemans MJC, Harrell FE Jr, Habbema JDF. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19(8):1059–1079. doi:10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0
   PubMed Web of Science ®Google Scholar
• Boffa MC, Karochkine M, Berard M. Plasma thrombomodulin as a marker of endothelium damage. Nouv Rev Fr Hematol. 1991;33(6):529–530.
   PubMedGoogle Scholar
• Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357(13):1301–1310. doi:10.1056/NEJMoa064278
   PubMed Web of Science ®Google Scholar
• Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 1996;124:S11–S20. doi:10.1016/0021-9150(96)05852-2
   PubMed Web of Science ®Google Scholar
• Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62(5):707–714. doi:10.1016/0002-9343(77)90874-9
   PubMed Web of Science ®Google Scholar
• Curb JD, Abbott RD, Rodriguez BL, et al. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res. 2004;45(5):948–953. doi:10.1194/jlr.M300520-JLR200
   PubMed Web of Science ®Google Scholar
• Lakka H-M, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709–2716. doi:10.1001/jama.288.21.2709
   PubMed Web of Science ®Google Scholar
• Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the triglyceride–HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med. 2005;165(12):1395–1400. doi:10.1001/archinte.165.12.1395
   PubMedGoogle Scholar
• Blondon M, Cushman M, Jenny N, et al. Associations of serum 25-hydroxyvitamin D with hemostatic and inflammatory biomarkers in the multi-ethnic study of atherosclerosis. J Clin Endocrinol Metab. 2016;101(6):2348–2357. doi:10.1210/jc.2016-1368
   PubMedGoogle Scholar
• Wang Q, Zhu Z, Liu Y, Tu X, He J. Relationship between serum vitamin D levels and inflammatory markers in acute stroke patients. Brain Behav. 2018;8(2):e00885. doi:10.1002/brb3.885
   PubMed Web of Science ®Google Scholar
• Dauletbaev N, Herscovitch K, Das M, et al. Down‐regulation of IL‐8 by high‐dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up‐regulation of DUSP1. Br J Pharmacol. 2015;172(19):4757–4771. doi:10.1111/bph.13249
   PubMedGoogle Scholar
• Adegoke SA, Smith OS, Adekile AD, Figueiredo MS. Relationship between serum 25-hydroxyvitamin D and inflammatory cytokines in paediatric sickle cell disease. Cytokine. 2017;96:87–93. doi:10.1016/j.cyto.2017.03.010
   PubMed Web of Science ®Google Scholar
• Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem. 1989;264(9):4743–4746.
   PubMed Web of Science ®Google Scholar
• Remková A, Kováčová E, Príkazská M, Kratochvíl’ová H. Thrombomodulin as a marker of endothelium damage in some clinical conditions. Eur J Intern Med. 2000;11(2):79–84. doi:10.1016/S0953-6205(00)00066-2
   PubMedGoogle Scholar
• Wang M, Gao P, Wu X, et al. Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma. Respir Res. 2016;17(1):153. doi:10.1186/s12931-016-0462-0
   PubMed Web of Science ®Google Scholar
• Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension. 2011;57(1):63–69. doi:10.1161/HYPERTENSIONAHA.110.160929
   PubMed Web of Science ®Google Scholar
• Janjetovic Z, Zmijewski MA, Tuckey RC, et al. 20-hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-κB activity by increasing IκBα levels in human keratinocytes. PLoS One. 2009;4(6):e5988. doi:10.1371/journal.pone.0005988
   PubMed Web of Science ®Google Scholar
• Sohn RH, Deming CB, Johns DC, et al. Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood. 2005;105(10):3910–3917. doi:10.1182/blood-2004-03-0928
   PubMedGoogle Scholar